1) La descarga del recurso depende de la página de origen
2) Para poder descargar el recurso, es necesario ser usuario registrado en Universia


Opción 1: Descargar recurso

Detalles del recurso

Descripción

The chromosome 16p13 region has been associated with several autoimmune diseases, including type 1 diabetes (T1D) and multiple sclerosis (MS). CLEC16A has been reported as the most likely candidate gene in the region, since it contains the most disease-associated single-nucleotide polymorphisms (SNPs), as well as an imunoreceptor tyrosine-based activation motif. However, here we report that intron 19 of CLEC16A, containing the most autoimmune disease-associated SNPs, appears to behave as a regulatory sequence, affecting the expression of a neighbouring gene, DEXI. The CLEC16A alleles that are protective from T1D and MS are associated with increased expression of DEXI, and no other genes in the region, in two independent monocyte gene expression data sets. Critically, using chromosome conformation capture (3C), we identified physical proximity between the DEXI promoter region and intron 19 of CLEC16A, separated by a loop of >150 kb. In reciprocal experiments, a 20 kb fragment of intron 19 of CLEC16A, containing SNPs associated with T1D and MS, as well as with DEXI expression, interacted with the promotor region of DEXI but not with candidate DNA fragments containing other potential causal genes in the region, including CLEC16A. Intron 19 of CLEC16A is highly enriched for transcription-factor-binding events and markers associated with enhancer activity. Taken together, these data indicate that although the causal variants in the 16p13 region lie within CLEC16A, DEXI is an unappreciated autoimmune disease candidate gene, and illustrate the power of the 3C approach in progressing from genome-wide association studies results to candidate causal genes.

Pertenece a

PubMed Central (PMC3 - NLM DTD)  

Autor(es)

Davison, Lucy J. -  Wallace, Chris -  Cooper, Jason D. -  Cope, Nathan F. -  Wilson, Nicola K. -  Smyth, Deborah J. -  Howson, Joanna M.M. -  Saleh, Nada -  Al -  Jeffery, Abdullah -  Angus, Karen L. -  Stevens, Helen E. -  Nutland, Sarah -  Duley, Simon -  Coulson, Richard M.R. -  Walker, Neil M. -  Burren, Oliver S. -  Rice, Catherine M. -  Cambien, Francois -  Zeller, Tanja -  Munzel, Thomas -  Lackner, Karl -  Blankenberg, Stefan -  Fraser, Peter -  Gottgens, Berthold -  Todd, John A. - 

Id.: 55021020

Idioma: inglés  - 

Versión: 1.0

Estado: Final

Palabras claveArticles - 

Tipo de recurso: Text  - 

Tipo de Interactividad: Expositivo

Nivel de Interactividad: muy bajo

Audiencia: Estudiante  -  Profesor  -  Autor  - 

Estructura: Atomic

Coste: no

Copyright: sí

Requerimientos técnicos:  Browser: Any - 

Fecha de contribución: 11-feb-2012

Contacto:

Localización:

Otros recursos del mismo autor(es)

  1. The heterogeneity of systemic inflammation in bronchiectasis. BACKGROUND: Systemic inflammation in bronchiectasis is poorly studied in relation to aetiology and s...
  2. Guest/Host Relationships in the Synthesis of the Novel Cage-Based Zeolites SSZ-35, SSZ-36, and SSZ-39 Here, we report the synthesis and structure of three high-silica molecular sieves, SSZ-35, SSZ-36, a...
  3. A Three-Site Mechanism for Agonist/Antagonist Selective Binding to Vasopressin Receptors
  4. Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics. There is currently an urgent need for biomarkers that can be used to monitor the efficacy of experim...
  5. Prevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice. Duchenne muscular dystrophy (DMD) is a fatal neuromuscular disorder caused by mutations in the Dmd g...

Otros recursos de la mismacolección

No existen otros recursos

Aviso de cookies: Usamos cookies propias y de terceros para mejorar nuestros servicios, para análisis estadístico y para mostrarle publicidad. Si continua navegando consideramos que acepta su uso en los términos establecidos en la Política de cookies.